Ad
related to: edwards lifesciences draper- TAVR Valves
Your valve choice matters.
Read about TAVR valve options.
- TAVR Procedure
Learn what to expect
from your TAVR Procedure.
- Treatment Options
Learn about your treatment options
for SAS with symptoms.
- Important Risk Info
Read important risk information
about TAVR by Edwards
- Helpful Patient Resources
Get helpful tools and resources.
Get your TAVR info kit.
- Hear From TAVR Patients
See stories of patients treated
for SAS with symptoms.
- TAVR Valves
Search results
Results From The WOW.Com Content Network
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the SAPIEN transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter . [ 4 ]
On Wednesday, during its annual investor conference, Edwards Lifesciences Corporation (NYSE:EW) detailed its strategy for sustained long-term growth and innovations in structural heart therapies.
Edwards Lifesciences Corporation (NYSE:EW) shares are trading higher on Thursday. Stifel analyst Rick Wise upgraded Edwards from Hold to Buy, raising the price forecast to $90 from $75. Wise ...
Draper Laboratory is an American non-profit research and development organization, headquartered in Cambridge, Massachusetts; its official name is The Charles Stark Draper Laboratory, Inc. [6] The laboratory specializes in the design, development, and deployment of advanced technology solutions to problems in national security, space ...
Edwards Lifesciences is a leader in replacement heart valves and monitors for blood movement and pressure. The medical device maker has been on one heck of a run over the last few years, which ...
Molten Ventures, formerly Draper Esprit, is a British venture capital firm, investing in high growth technology companies with global ambitions. The firm has offices in London, Cambridge and Dublin. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.
Transcatheter aortic valve replacement (TAVR) device, Edwards' lead product, which has been facing rising competition from other med-tech peers, posted a 12.9% rise in revenue to $979.4 million.
Of the several pericardial valves built since 1980, some have been abandoned early and only three have stood the test of time. These three modified and improved pericardial valves were made respectively by Mitral Medical Inc. (now part of the Sorin group), Edwards Laboratories (now Edwards Lifesciences) [54] and the Sorin Group. [55]
Ad
related to: edwards lifesciences draper